Cleared Traditional

ARCHITECT B.R.A.H.M.S PCT, ARCHITECT B.R.A.H.M.S PCT Calibrators, ARCHITECT B.R.A.H.M.S PCT Controls

K170652 · Fisher Diagnostics · Microbiology

Jun 2017

Decision

90d

Days

Class 2

Risk

About This 510(k) Submission

K170652 is an FDA 510(k) clearance for the ARCHITECT B.R.A.H.M.S PCT, ARCHITECT B.R.A.H.M.S PCT Calibrators, ARCHITECT B.R.A.H.M.S PCT Controls, a Procalcitonin Assay (Class II — Special Controls, product code PRI), submitted by Fisher Diagnostics (Middletown, US). The FDA issued a Cleared decision on June 1, 2017, 90 days after receiving the submission on March 3, 2017. This device falls under the Microbiology review panel. Regulated under 21 CFR 866.3215.

Submission Details

510(k) Number	K170652 FDA.gov
FDA Decision	Cleared SESE
Date Received	March 03, 2017
Decision Date	June 01, 2017
Days to Decision	90 days
Submission Type	Traditional
Review Panel	Microbiology (MI)
Summary	Summary PDF

Device Classification

Product Code	PRI — Procalcitonin Assay
Device Class	Class II — Special Controls
CFR Regulation	21 CFR 866.3215
Definition	To Aid In Decision Making On Antibiotic Therapy, Including Antibiotic Initiation And Discontinuation, For Inpatients Or Patients In The Emergency Department, With Suspected Or Confirmed Lower Respiratory Tract Infections (lrti) Defined As Community-acquired Pneumonia (cap), Acute Bronchitis, And Acute Exacerbation Of Chronic Obstructive Pulmonary Disease (aecopd).